Lebanon News

Motilium to remain in market despite Euro ban

A Motilium medicine pack by Belgium pharmaceutical Janssen Cilag laboratory. AFP PHOTO/PHILIPPE HUGUEN

BEIRUT: Despite a recent call by medical journal Prescrire to remove the anti-nausea drug domperidone from European markets, it will be available in Lebanon at least for now. 

The journal links the drug, commonly sold under the brand name Motilium, to cardiac arrest, and suggests that as many as 120 patients in France died from consuming the medication in 2012. 

The Health Ministry issued a statement Friday saying that “the state has not yet made a decision to recall” Motilium from Lebanese pharmacies, but that it follows the scientific research and warnings closely.

A version of this article appeared in the print edition of The Daily Star on February 22, 2014, on page 2.




Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (

comments powered by Disqus



Interested in knowing more about this story?

Click here